The UK Health Security Agency (UKHSA) said last week (Aug 5) there were "early signs" that the monkeypox outbreak was plateauing across the country and that
its expansion had slowed.
"While the most recent data suggests the growth of the outbreak has slowed, we cannot be complacent," Dr Meera Chand, director of clinical and emerging infections
at UKHSA, said.
There were 2,859 confirmed and highly probable cases of monkeypox in the UK as of Aug. 4, with nearly 99 per cent of the cases among men, the country's health
authority said in a statement.
The recent analysis by the UKHSA showed that "monkeypox continues to be transmitted primarily in interconnected sexual networks of gay, bisexual, or other men who
have sex with men", it added.
British authorities in June were recommending gay and bisexual men at higher risk of exposure to monkeypox be offered a vaccine, as the outbreak of the viral disease
had gathered pace, mostly in Europe.
The UK Health Security Agency (UKHSA) has advised self-isolation for people diagnosed with monkeypox to reduce the risk of spreading the infection.
Household members are at the highest risk of becoming infected from a case within their house. The new guidance advises people with monkeypox infection to take steps to try and limit transmission within the household.
"Monkeypox infection mainly spreads between people through direct, skin-to-skin contact, including sexual contact. Infection can also be spread via contaminated
objects such as linen and soft furnishings," said UKHSA.
The guidance advises that, where possible, cases are encouraged to sleep and eat in a separate room and use a separate bathroom to their household if possible. Good hygiene measures, to follow at all times, have also been set out.
It suggests, "Where the use of a separate room isn't possible, cases should avoid physical contact and keep at least three steps (one metre) away from all household
members. It is particularly important that they avoid close contact with young children, pregnant women and immunosuppressed people as they may be at higher risk of serious illness."
People infected with monkeypox can isolate at home if they remain well enough, whilst following measures to limit close contact with others, the UK's health
security agency (UKHSA) said on Monday (May 30), part of guidance designed to curb the country's rise in cases of the viral illness.
More than 300 suspected and confirmed cases of monkeypox have been reported in May, outside of Africa where the virus is endemic. The usually mild illness spreads
through close contact and can cause flu-like symptoms and pus-filled skin lesions.
An additional 71 cases of monkeypox have been identified in England, taking the total number of confirmed cases in the UK as a whole to 179 since early May.
Scientists are looking into what might explain the unusual surge of cases, given most are not linked to travel.
The UKHSA indicated community transmission was occurring in the UK and said infected people should avoid contact with others until their lesions have healed and
the scabs have dried off.
The British scientists behind one of the major therapeutic Covid-19 trials have turned their focus to treatments for monkeypox, a viral disease that has been
labelled a global health emergency by the World Health Organization.
The team from Oxford University behind the so-called RECOVERY trial - which honed in on four effective Covid treatments - on Tuesday unveiled a new trial, dubbed
PLATINUM, to confirm whether Siga Technologies' tecovirimat is an effective treatment for monkeypox.
Although there are vaccines developed for the closely related smallpox that can reduce the risk of catching monkeypox, there are currently no treatments that have
been proven to help hasten recovery in those who develop the disease.
The UK has over 3,000 confirmed cases of monkeypox.
The virus is transmitted chiefly through close contact with an infected person. It typically causes mild symptoms including fever, rash, swollen lymph nodes and
pus-filled skin lesions. Severe cases can occur, though people tend to recover within two to four weeks.
Siga's drug, branded Tpoxx, has been cleared to treat diseases caused by the family of orthopoxvirus that includes smallpox, monkeypox and cowpox by the European
Union and United Kingdom, but due to limited trial data it is generally only used in severe cases in Britain.
A total of 37 more cases of monkeypox have been detected in England and Scotland, public health officials said on Monday, taking the total to 57.
Thirty-six confirmed cases were found in England, and one north of the border, the UK Health Security Agency and Public Health Scotland said.
The UKHSA said it was now advising high-risk contact cases of confirmed cases who have not tested positive or developed symptoms to isolate for up to 21 days.
It has also bought supplies of smallpox vaccine, which is being offered to close contacts to reduce the risk of symptomatic infection and severe illness.
Chief medical adviser Susan Hopkins said contact tracing was helping to limit the close-contact spread of the virus, which causes a chickenpox-like rash.
"Because the virus spreads through close contact, we are urging everyone to be aware of any unusual rashes or lesions and to contact a sexual health service if they have any symptoms," she added in a statement.
A person in England has been diagnosed with a rare viral monkeypox infection thought to be linked to travel to West Africa, health authorities said at the weekend (May 7).
The UK Health Security Agency (UKHSA) said in a statement the case, in a person who had recently traveled to Nigeria, was being treated at an expert respiratory infectious disease unit at Guy's and St Thomas' NHS Foundation Trust in London.
"It is important to emphasise that monkeypox does not spread easily between people and the overall risk to the general public is very low," said Colin Brown, director of clinical and emerging infections at UKHSA.